⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

February 22, 2019European Journal of Neurology

Clinical applicability of diagnostic biomarkers in early‐onset cognitive impairment

View Full Paper

Ask AI

Bookmark

Share

Abstract

Biomarker procedures are well tolerated and have an important diagnostic/therapeutic impact on early-onset cognitive impairment.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Falgàs et al. (2019) studied this question.

synapsesocial.com/papers/69d82f0652654bb436d1856d https://doi.org/10.1111/ene.13945

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Clinical features and <i>APOE</i> genotype of pathologically proven early-onset Alzheimer diseaseRetrospective Study · 2011 · 151 citations
2The Accurate Diagnosis of Early-Onset DementiaCross-Sectional Study · 2006 · 184 citations
3The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseClinical Trial · 2011 · 10,470 citations
4The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseClinical Trial · 2011 · 19,187 citations
5Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementiaDiagnostic Study · 2011 · 5,235 citations